Sweet syndrome induced by SARS-CoV-2 vaccines: A systematic review of patient-report studies

Since COVID-19 became a global pandemic in 2020, the development and application of SARS-CoV-2 vaccines has become an important task to prevent the spread of the epidemic. In addition to the safety and efficacy of COVID-19 vaccines, the adverse reactions caused by vaccines in a small number of peopl...

Full description

Bibliographic Details
Main Authors: Yilai Jia, Boyang Fu, Liping Dong, Mingyi Zhao
Format: Article
Language:English
Published: Taylor & Francis Group 2023-08-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2023.2217076
_version_ 1797673034032611328
author Yilai Jia
Boyang Fu
Liping Dong
Mingyi Zhao
author_facet Yilai Jia
Boyang Fu
Liping Dong
Mingyi Zhao
author_sort Yilai Jia
collection DOAJ
description Since COVID-19 became a global pandemic in 2020, the development and application of SARS-CoV-2 vaccines has become an important task to prevent the spread of the epidemic. In addition to the safety and efficacy of COVID-19 vaccines, the adverse reactions caused by vaccines in a small number of people also deserve our attention. We aimed to discuss and analyze the possible causes of Sweet syndrome caused by the COVID-19 vaccine by integrating the effective information from 16 patients and combining it with the latest views on the innate immune mechanism. We searched the PubMed and Embase databases for published patient reports on the occurrence or recurrence of Sweet syndrome after COVID-19 vaccination. We summarized the basic information of the patients, the type of vaccination, the presence of underlying diseases, and the clinical manifestations, clinical treatment and prognosis of the patients. The results were reported in narrative methods and were sorted into tables. We initially identified 53 studies. 16 articles were included through full-text screening. Based on the table we compiled, we generally concluded that the first dose of any type of COVID-19 vaccine was more likely to cause Sweet syndrome than subsequent doses. Sweet syndrome may occur after COVID-19 vaccination. Clinicians should consider Sweet syndrome in addition to common adverse reactions such as anaphylaxis and infection when a patient presents with acute fever accompanied by nodular erythema, pustules, and edematous plaques after COVID-19 vaccination.
first_indexed 2024-03-11T21:39:38Z
format Article
id doaj.art-4953df36a025495782cafb1cf645dfa6
institution Directory Open Access Journal
issn 2164-5515
2164-554X
language English
last_indexed 2024-03-11T21:39:38Z
publishDate 2023-08-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj.art-4953df36a025495782cafb1cf645dfa62023-09-26T13:25:50ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2023-08-0119210.1080/21645515.2023.22170762217076Sweet syndrome induced by SARS-CoV-2 vaccines: A systematic review of patient-report studiesYilai Jia0Boyang Fu1Liping Dong2Mingyi Zhao3Central South UniversityCentral South UniversityChangsha Medical UniversityCentral South UniversitySince COVID-19 became a global pandemic in 2020, the development and application of SARS-CoV-2 vaccines has become an important task to prevent the spread of the epidemic. In addition to the safety and efficacy of COVID-19 vaccines, the adverse reactions caused by vaccines in a small number of people also deserve our attention. We aimed to discuss and analyze the possible causes of Sweet syndrome caused by the COVID-19 vaccine by integrating the effective information from 16 patients and combining it with the latest views on the innate immune mechanism. We searched the PubMed and Embase databases for published patient reports on the occurrence or recurrence of Sweet syndrome after COVID-19 vaccination. We summarized the basic information of the patients, the type of vaccination, the presence of underlying diseases, and the clinical manifestations, clinical treatment and prognosis of the patients. The results were reported in narrative methods and were sorted into tables. We initially identified 53 studies. 16 articles were included through full-text screening. Based on the table we compiled, we generally concluded that the first dose of any type of COVID-19 vaccine was more likely to cause Sweet syndrome than subsequent doses. Sweet syndrome may occur after COVID-19 vaccination. Clinicians should consider Sweet syndrome in addition to common adverse reactions such as anaphylaxis and infection when a patient presents with acute fever accompanied by nodular erythema, pustules, and edematous plaques after COVID-19 vaccination.http://dx.doi.org/10.1080/21645515.2023.2217076sars-cov-2vaccinesweet syndrometrained immunity
spellingShingle Yilai Jia
Boyang Fu
Liping Dong
Mingyi Zhao
Sweet syndrome induced by SARS-CoV-2 vaccines: A systematic review of patient-report studies
Human Vaccines & Immunotherapeutics
sars-cov-2
vaccine
sweet syndrome
trained immunity
title Sweet syndrome induced by SARS-CoV-2 vaccines: A systematic review of patient-report studies
title_full Sweet syndrome induced by SARS-CoV-2 vaccines: A systematic review of patient-report studies
title_fullStr Sweet syndrome induced by SARS-CoV-2 vaccines: A systematic review of patient-report studies
title_full_unstemmed Sweet syndrome induced by SARS-CoV-2 vaccines: A systematic review of patient-report studies
title_short Sweet syndrome induced by SARS-CoV-2 vaccines: A systematic review of patient-report studies
title_sort sweet syndrome induced by sars cov 2 vaccines a systematic review of patient report studies
topic sars-cov-2
vaccine
sweet syndrome
trained immunity
url http://dx.doi.org/10.1080/21645515.2023.2217076
work_keys_str_mv AT yilaijia sweetsyndromeinducedbysarscov2vaccinesasystematicreviewofpatientreportstudies
AT boyangfu sweetsyndromeinducedbysarscov2vaccinesasystematicreviewofpatientreportstudies
AT lipingdong sweetsyndromeinducedbysarscov2vaccinesasystematicreviewofpatientreportstudies
AT mingyizhao sweetsyndromeinducedbysarscov2vaccinesasystematicreviewofpatientreportstudies